Хроническая болезнь почек у пациентов пожилого и старческого возраста с коморбидной патологией

Обзор посвящен анализу текущих данных по проблемам диагностики и лечения хронической болезни почек у пациентов пожилого и старческого возраста с коморбидной патологией. В работе рассматриваются основные виды коморбидной патологии в совокупности с хронической болезнью почек. На основе анализа современной литературы выделены ключевые направления для дальнейших исследований. Полученные данные подчеркивают важность отдельного подхода к диагностике и лечению данного заболевания у пациентов пожилого и старческого возраста с коморбидной патологией. Проведенный литературный обзор подчеркивает необходимость комплексного подхода к ведению пациентов пожилого и старческого возраста с коморбидной патологией, включая раннюю диагностику, тщательную оценку коморбидных состояний и своевременное начало лечения, направленного на замедление прогрессирования заболевания и улучшение качества жизни. В дальнейшем требуется проведение дополнительных исследований для более глубокого понимания механизмов взаимодействия хронической болезни почек с другими заболеваниями у пожилых пациентов, а также разработки новых подходов к диагностике и лечению. 

1. Ferrer A., Formiga F., Henríquez E., Lombarte I., Olmedo C., Pujol R. Evaluación funcional y cognitiva en una población urbana de mayores de 89 años. Estudio NonaSantfeliu. Rev. Esp. Geriatr. Gerontol . 2006; 41: 21-26.

2. Kooman J.P., van der Sande F.M., Leunissen K.M. Kidney disease and aging: A reciprocal relation. Exp. Gerontol . 2017; 87: 156-159. https://doi.org/10.1016/j.exger.2016.02.003

3. Stevens L.A., Viswanathan G., Weiner D.E. Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future Adv. Chronic projections, and clinical significance. Kidney Dis . 2010; 17 (4): 293-301. https://doi.org/10.1053/j.ackd.2010.03.010.

4. Chow E., Merchant A.A., Molnar F., Frank C. Approach to chronic kidney disease in the elderly. Can. Fam. Physician . 2023; 69 (1): 25-27. https://doi.org/10.46747/cfp.690125

5. Roderick P.J., Atkins R.J., Smeeth L., Nitsch D.M., Hubbard R.B., Fletcher A.E., et al. Detecting chronic kidney disease in older people; what are the implications? Age Ageing. 2008; 37: 179-186. https://doi.org/10.1093/ageing/afm180

6. Lamb E.J., Levey A.S., Stevens P.E. The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution. Clin. Chem. 2013; 59 (3): 462-465. https://doi.org/10.1373/clinchem.2012.184259

7. Jha V., Garcia-Garcia G., Iseki K., Li Z., Naicker S., Plattner B., Saran R., Wang A.Y., Yang C.W. Chronic kidney disease: global dimension and perspectives. Lancet . 2013; 382 (9888): 260-272. https://doi.org/10.1016/S0140-6736(13)60687-X

8. Liyanage T., Ninomiya T., Jha V., Neal B., Patrice H.M., Okpechi I., Zhao M.H., Lv J., Garg A.X., Knight J., Rodgers A., Gallagher M., Kotwal S., Cass A., Perkovic V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet . 2015; 385 (9981): 1975-1982. https://doi.org/10.1016/S0140-6736(14)61601-9

9. Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res. Clin. Pract. 2014; 103 (2): 137-149. https://doi.org/10.1016/j.diabres.2013.11.002

10. Nanditha A., Ma R.C., Ramachandran A., Snehalatha C., Chan J.C., Chia K.S., Shaw J.E., Zimmet P.Z. Diabetes in Asia and the Pacific: Implications for the Global Epidemic. Diabetes Care. 2016; 39 (3): 472-485. https://doi.org/10.2337/dc15-1536. PMID: 26908931

11. Нурсултанова Л. Н. Распространенность хронической болезни почек в Казахстане (обзор литературы). Вестник Казахского Национального медицинского университета. 2020; 4: 291-294.

12. Webster A.C., Nagler E.V., Morton R.L., Masson P. Chronic Kidney Disease. The Lancet. 2017; 389: 1238-1252. https://doi.org/10.1016/ S0140-6736(16)32064-5

13. Brosnahan G.M., Abebe K.Z., Moore C.G., et al. Patterns of kidney function decline in autosomal dominant polycystic kidney disease: a post hoc analysis from the HALT-PKD trials. Am. J. Kidney. Dis. 2018; 71: 666-676. https://doi.org/10.1053/j. ajkd.2017.10.023

14. Formiga F., Ferrer A., Cruzado J.M., Padros G., Fanlo M., Roson B., Pujol R. Geriatric assessment and chronic kidney disease in the oldest old: the Octabaix study. Eur. J. Intern. Med. 2012; 23 (6): 534-538. https://doi.org/10.1016/j.ejim.2012.03.009

15. Colombo M.G., Förster C., Wallwiener S., Hassdenteufel K., Hawighorst-Knapstein S., Kirtschig G., Chaudhuri A., Dally S., Joos S. Comorbidity, life-style factors and healthcare utilization in incident chronic kidney disease: sex-specific analyses of claims data. Nephrol. Dial. Transplant. 2023; 38 (3): 722-732. https://doi.org/10.1093/ndt/gfac245

16. Hill N.R., Fatoba S.T., Oke J.L., et al. Global prevalence of chronic kidney disease -A systematic review and meta-analysis. PLoS One 2016; 11: e0158765. https://doi.org/10.1371/journal.pone.0158765

17. Gansevoort R.T., Correa-Rotter R., Hemmelgarn B.R., et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet . 2013; 382: 339-352. https://doi.org/10.1016/S0140-6736(13)60595-4

18. Bright R. Cases and Observations Illustrative of Renal Disease, Accompanied with the Secretion of Albuminous Urine. Med. Chir. Rev. 1836; 25 (49): 23-35.

19. Jankowski J., Floege J., Fliser D., Böhm M., Marx N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation . 2021; 143 (11): 1157-1172. https://doi.org/10.1161/CIRCULATIONAHA.120.050686

20. Stevens P.E., O’Donoghue D.J., de Lusignan S., Van Vlymen J., Klebe B., Middleton R., Hague N., New J., Farmer C.K. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 2007; 72: 92-99. https://doi.org/10.1038/sj.ki.5002273

21. Thompson S., James M., Wiebe N., Hemmelgarn B., Manns B., Klarenbach S., Tonelli M.; Alberta Kidney Disease Network. Cause of death in patients with reduced kidney function. J. Am. Soc. Nephrol. 2015; 26: 2504-2511. https://doi.org/10.1681/ASN.2014070714

22. Vanholder R., Argilés A., Baurmeister U., Brunet P., Clark W., Cohen G., De Deyn P.P., Deppisch R., Descamps-Latscha B., Henle T., et al. Uremic toxicity: present state of the art. Int. J. Artif. Organs. 2001; 24: 695-725. https://doi.org/10.1177/039139880102401004

23. Weiner D.E., Tighiouart H., Elsayed E.F., Griffith J.L., Salem D.N., Levey A.S., Sarnak M.J. The Framingham predictive instrument in chronic kidney disease. J. Am. Coll. Cardiol. 2007; 50: 217-224. https://doi.org/10.1016/j.jacc.2007.03.037

24. Roehm B., Weiner D.E. Blood pressure targets and kidney and cardiovascular disease: same data but discordant guidelines. Curr. Opin.Nephrol. Hypertens. 2019; 28: 245-250. https://doi.org/10.1097/MNH. 0000000000000492

25. McGonigle R.J., Wallin J.D., Shadduck R.K., Fisher J.W. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int. 1984; 25 (2): 437-444. https://doi.org/10.1038/ki.1984.36

26. Wouters H.J.C.M., van der Klauw M.M., de Witte T., Stauder R., Swinkels D.W., Wolffenbuttel B.H.R., Huls G. Association of anemia with health-related quality of life and survival: a large population-based cohort study. Haematologica . 2019; 104 (3): 468-476. https://doi.org/10.3324/haematol.2018.195552

27. Locatelli F., Nissenson A.R., Barrett B.J., Walker R.G., Wheeler D.C., Eckardt K.U., Lameire N.H., Eknoyan G. Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2008; 74 (10): 1237-1240. https://doi.org/10.1038/ki.2008.299

28. Moist L.M., Troyanov S., White C.T., Wazny L.D., Wilson J.A., McFarlane P., Harwood L., Sood M.M., Soroka S.D., Bass A., Manns B.J. Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am. J. Kidney Dis. 2013; 62 (5): 860-873. https://doi.org/10.1053/j.ajkd.2013.08.001

29. Ravender R., Roumelioti M.E., Schmidt D.W., Unruh M.L., Argyropoulos C. Chronic Kidney Disease in the Older Adult Patient with Diabetes. J. Clin. Med. 2024; 13 (2): 348. https://doi.org/10.3390/jcm13020348

30. Watanabe K., Okuro M., Okuno T., Iritani O., Yano H., Himeno T., Morita T., Igarashi Y., Nakahashi T., Morimoto S. Comorbidity of chronic kidney disease, diabetes and lower glycated hemoglobin predicts support/care-need certification in community-dwelling older adults. Geriatr. Gerontol. Int. 2018; 18 (4): 521-529. https://doi.org/10.1111/ggi.13211

31. Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., Marre M., Cooper M., Glasziou P., Grobbee D., et al; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 2008; 358: 2560-2572. https://doi.org/10.1056/NEJMoa0802987

32. Charles C., Ferris A.H. Chronic Kidney Disease. Prim Care. 2020; 47 (4): 585-595. https://doi.org/10.1016/j.pop.2020.08.001

33. Riddle M.C. Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation . 2010; 122: 844-846. https://doi.org/10.1161/CIRCULATIONAHA.110.960138

34. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., Zieve F.J., Marks J., Davis S.N., Hayward R., et al; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 2009; 360: 129-139. https://doi.org/10.1056/NEJMoa0808431

35. Mallappallil M., Friedman E.A., Delano B.G., McFarlane S.I., Salifu M.O. Chronic kidney disease in the elderly: evaluation and management. Clin. Pract. (Lond). 2014; 11 (5): 525-535. https://doi.org/10.2217/cpr.14.46

36. Maini R., Wong D.B., Addison D., Chiang E., Weisbord S.D., Jneid H. Persistent underrepresentation of kidney disease in randomized, controlled trials of cardiovascular disease in the contemporary era. J. Am. Soc. Nephrol. 2018; 29: 2782-2786. https://doi.org/10.1681/ASN.2018070674

37. Zewinger S., Kleber M.E., Rohrer L., Lehmann M., Triem S., Jennings R.T., Petrakis I., Dressel A., Lepper P.M., Scharnagl H., et al. Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease. Eur. Heart J. 2017; 38: 1597-1607. https://doi.org/10.1093/eurheartj/ehx118

38. Phoon R.K. Chronic kidney disease in the elderly assessment and management. Aust. Fam. Physician. 2012; 41 (12): 940-944.

39. Shroff R., Speer T., Colin S., Charakida M., Zewinger S., Staels B., Chinetti-Gbaguidi G., Hettrich I., Rohrer L., O’Neill F., et al. HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype. J. Am. Soc. Nephrol. 2014; 25: 2658-2668. https://doi.org/10.1681/ASN.2013111212

40. Mikolasevic I., Žutelija M., Mavrinac V., Orlic L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int. J. Nephrol. Renovasc. Dis. 2017; 10: 35-45. https://doi.org/10.2147/IJNRD.S101808

41. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021; 99 (3S): S1-S87. https://doi.org/10.1016/j.kint.2020.11.003

42. Kudina E.V., Skvortsov R.A., Larina V.N., Zhuk V.A., Ivanova M.Z. Elderly with chronic kidney disease in outpatient treatment: risk factors and prevention pathways. Russian Journal of Geriatric Medicine . 2021; 1: 53-59. https://doi.org/10.37586/2686-8636-1-2021-53-59

43. Liang X., Ye M., Tao M., Zheng D., Cai R., Zhu Y., Jin J., He Q. The association between dyslipidemia and the incidence of chronic kidney disease in the general Zhejiang population: a retrospective study. BMC Nephrol. 2020; 21 (1): 252. https://doi.org/10.1186/s12882-020-01907-5

44. Kelly D.M., Anders H.-J., Bello A.K., et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe. Kidney International Supplements.2021; 11: e106-e118. https://doi.org/10.1016/j. kisu.2021.01.007

45. Saran R., Robinson B., Abbott K.C., et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. American Journal of Kidney Diseases. 2019; 73: A7A8. https://doi.org/10.1053/j.ajkd.2019.01.001

46. Thomas M.C., Cooper M.E., Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat. Rev. Nephrol. 2016; 12: 73-81. https://doi.org/10.1038/nrneph.2015.173

47. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., Eknoyan G. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Annals of Internal Medicine . 2003; 139 (2): 137. https://doi.org/10.7326/0003-4819-139-2200307150-00013

48. Ma I., Guo M., Muruve D., Benediktsson H., Naugler C. Sociodemographic associations with abnormal estimated glomerular filtration rate (eGFR) in a large Canadian city: a cross-sectional observation study. BMC Nephrol. 2018; 19: 198. https://doi.org/10.1186/s12882-018-0991-5

49. Komenda P., Lavallee B., Ferguson T.W., Tangri N., Chartrand C., McLeod L., Gordon A., Dart A., Rigatto C. The Prevalence of CKD in Rural Canadian Indigenous Peoples: Results From the First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis (FINISHED) Screen, Triage, and Treat Program. Am. J. Kidney Dis. 2016; 68 (4): 582-590. https://doi.org/10.1053/j.ajkd.2016.04.014

50. Philipneri M.D., Rocca Rey L.A., Schnitzler M.A., Abbott K.C., Brennan D.C., Takemoto S.K., Lentine K.L. (). Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clinical and Experimental Nephrology . 2008; 12 (1): 41-52. https://doi.org/10.1007/ s10157-007-0016-3

51. Vassalotti J.A., Li S., McCullough P.A., Bakris G.L. Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease. Semin. Nephrol. 2010; 30 (1): 66-73. https://doi.org/10.1016/j.semnephrol.2009.10.004